(MENAFN- America News Hour)
Kenneth Research examined the statistical and analytical approach that is required for the growth of Molecular Diagnostics industry market between the years 2022 and 2031. The key industrial insights provided in the report gives a better idea about the market overview to the readers regarding the existing scenario in the market. In addition, the report includes detailed discussion on current and future market trends that are associated with the growth of the market.
Global Molecular Diagnostics Industry was valued at USD 6.72 Billion in the year 2017. Global Molecular Diagnostics Industry is further expected to grow at a CAGR of 11. 60% from 2018 to reach USD 16.15 Billion by the year 2025. North America region holds the highest Industry share in 2017. While Asia Pacific region is considered as the fastest growing Industry in the forecasted period. The U.S. is the major Industry in 2017 at country level and it is further anticipated to grow at a steady pace in the next 5 years.
The major Industry players in Molecular Diagnostics Industry are Abbott Laboratories, Beckman Coulter Inc., Biomerieux SA, Grifols SA, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Qiagen Netherlands, Danaher Corporation Lab 21, Agilent Technologies, Trinity Biotech and other 13 companies detailed information is provided in research report . Roche Diagnostics holds major Industry share in molecular diagnostics Industry for better global presence both at production and at an operational level. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key Industry drivers. Organic growth strategies adopted by most of Tier 1 and Tier 2 manufacturers in recent years is also providing comprehensive Industry opportunities for the various stakeholder.
Download Sample PDF of this Report :-
SWOT Analysis of Molecular Diagnostics Industry
Strengths
Molecular diagnostics advancements
Growing infectious disease Industry
Weakness
Lack of regulatory standards
Level of required financial investment & lack of technical expertise
Opportunity
Rising importance of diagnostics in improving healthcare quality
Development of emerging Industry for Point of care testing.
Threats
Intense competition and reduced healthcare reimbursement
By type, the Industry is segmented as instruments, software and Services and Reagents & Kits. The Polymerase Chain Reaction (PCR) is likely to hold the top Industry share during the forecast period among all other technology segments. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income). On the other hand, hospitals & clinical Laboratories for users is expected to grow at the highest CAGR of XXX during the year 2018-2025.
Request Free Sample Copy :-
Molecular Diagnostics Industry Overview
By type
Introduction
Instruments
Software and Services
Reagents & Kits
By Technology
Hybridization
Polymerase Chain Reaction (PCR)
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing
Others
By Users
Hospitals
Laboratories
Others
By Region
North America
? USA
? Canada
Europe
? Germany
? U.K.
? France
? Italy
? Rest of Europe
APAC
? China
? India
? Japan
? Rest of Asia-Pacific
RoW
? Latin America
? Middle East & Africa
Download Sample PDF of this Report :-
About Kenneth Research
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
MENAFN08072022004545010068ID1104499523
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.